Cephalon, Inc. was a U.S. biopharmaceutical company co-founded in 1987 by Frank Baldino, Jr, pharmacologist, Michael Lewis, neuroscientist and James C.
On October 14, 2011, Cephalon Inc. became a wholly owned subsidiary of Teva and ceased to be traded on NASDAQ. Pursuant to the merger agreement ...
Cephalon, Inc. engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. It offers NUVIGIL (armodafinil ) ...
Oct 12, 2016 ... Food & Drug Administration (FDA) (CLOSED). United States v. Cephalon, Inc., 2: 08-cr-00598 (E.D. Pa.) Most recent update 10/16/08 (See end ...
Cephalon, Inc. Cephalon, Inc. is now part of Teva Pharmaceutical Industries Ltd. ( October 2011). See: Teva Pharmaceuticals USA, Inc.
Cephalon, Inc. is an international biopharmaceutical company that specializes ... Cephalon has three proprietary products that account for almost all of its sales ...
Cephalon Inc. was established in 1987 as a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to ...
Cephalon Inc. financial and business news, updates, and information from The New York Times and other leading providers.